Rakon (RAK) / HY23

PBT up 15% but operating cash collapsed to zero on a $28m inventory build

Underlying earnings growth looks real, but a tax normalisation and a sharp working-capital draw have hidden the quality deterioration.

Release date
24 November 2022
Published
21 April 2026

What changed

Revenue edged up 2.0% to NZ$87.2m and underlying EBITDA rose 6.4% to NZ$28.1m, with operating profit up 19.9% to NZ$22.9m and PBT up 15.2% to NZ$22.4m. NPAT, however, fell 15.4% to NZ$16.0m because the effective tax rate normalised from 2.7% to 28.5% — a 30.6pp gap between PBT growth and NPAT growth that is entirely tax-driven, not operational.

Cash told a very different story. Operating cash flow collapsed from NZ$4.5m to NZ$0.0m while capex more than doubled to NZ$9.4m (10.8% of revenue versus 4.7% a year ago), producing pre-lease free cash flow of roughly −NZ$9.4m. The swing was absorbed by a NZ$28.5m inventory build, with inventories up 65.4% to NZ$72.0m and implied inventory days stretching to ~301 from ~189.

Despite that, the balance sheet optically strengthened: cash rose to NZ$25.7m, gross borrowings fell to NZ$7.3m from NZ$16.3m, and the group moved to a net cash position of ~NZ$18.4m (vs ~NZ$3.6m). Revenue concentration remains NZ-heavy at ~71%, with France/India at ~23.5% and France HiRel at ~10.7%.

What matters

  • Earnings quality read is PBT, not NPAT. The headline NPAT decline is a tax artefact; PBT up 15.2% on 2% revenue growth is the cleaner operating signal. Gross margin did compress ~97bps to 49.9%, so the EBITDA gain came more from operating leverage/cost control than from pricing.
  • Cash conversion has broken. OCF/EBITDA went from 17.1% to 0.1%. That is not a rounding issue — it is a working-capital event, and the inventory line identifies where the cash went. Whether this is pre-positioning for second-half demand or stranded stock is the single most important question in this result.
  • Balance sheet direction is ambiguous. Net debt improved sharply, but the improvement pre-dates the current period's cash burn; the NZ$18.4m net cash position coexists with materially heavier capex (~NZ$9.4m) and a large inventory carry. If the inventory does not unwind, the net cash buffer will thin quickly.

Expectations

No forward guidance, order book, or quantitative target was disclosed in the extracted release. On shape, HY22 was 49.7% of FY22 revenue but 57.2% of FY22 NPAT, so the prior year was modestly second-half weighted on revenue but first-half weighted on profit. Annualising HY23 revenue gives ~NZ$174.3m, only marginally above FY22's NZ$172.0m — so the release does not support a step-change in the top-line trajectory. It does support a stable-to-slightly-improving underlying earnings base on a pre-tax view, but it does not support confidence in cash delivery without a second-half inventory unwind.

Quality of result

Mixed. The pre-tax earnings improvement appears durable in the sense that it is driven by operating profit up NZ$3.8m on near-flat gross profit (NZ$43.5m vs NZ$43.5m) — i.e. cost discipline below the gross line rather than a margin expansion story. EBITDA growth of 6.4% on 2% revenue growth is consistent with that read.

However, the result is heavily balance-sheet-assisted in cash terms. Without the inventory build, operations would have thrown off materially more cash; with it, the business is funding growth through working capital and capex and producing negative free cash flow. ROE weakened to 11.5% from 15.7%, consistent with an enlarged asset base (total assets up 23.1% to NZ$218.4m) not yet translating into proportional earnings. Underlying EBITDA is also a non-GAAP measure with no reconciliation table in the extract, which limits how cleanly it can be relied on in isolation.

Unresolved

  • Is the NZ$28.5m inventory build demand-led pre-positioning, a supply-chain buffer, or slow-moving stock that will need to be written down?
  • What drove the 97bps gross margin compression — input costs, product mix, or pricing?
  • Why did capex step up to 10.8% of revenue, and is this a new run-rate tied to the India facility or a one-off?
  • What is the dividend position for the period? The extraction flags an "Interim/Final Dividend" line but no amount is captured.
  • How much of the NZ$6.3m FX uplift to cash flatters the reported cash position, given disclosed multi-currency operations?

This briefing cannot assess customer concentration, forward order book, or segment profitability, as none of these were disclosed in the supplied excerpts.

Key metrics

← Swipe to view more
Metric HY23 HY22 Change
Revenue $87.2m $85.4m +2.0% ↑
EBITDA $28.1m $26.4m +6.4% ↑
Net profit after tax $16.0m $18.9m -15.4% ↓
Net cash inflow from operating activities $0.0m $4.5m -99.6% ↓
Operating profit $22.9m $19.1m +19.9% ↑
Profit before tax $22.4m $19.5m +15.2% ↑
Cash and cash equivalents $25.7m $19.9m +29.2% ↑
Total assets $218.4m $177.4m +23.1% ↑

Reference: annolyse.ai/briefings/rak-hy23

Segment breakdown

← Swipe to view more
Segment Current revenue Prior revenue Current result Mix shift
NZ $61.9m n/a
France/India $20.5m n/a
France HiRel $9.4m n/a
Other −$4.6m n/a

Reference: annolyse.ai/briefings/rak-hy23

Analytical metrics

← Swipe to view more
Metric HY23 HY22 Context
PBT growth +15.2% cleaner earnings measure
Effective tax rate 28.5% 2.7%
OCF / EBITDA (cash conversion) 0.1% 17.1% deteriorated
FCF pre-lease −$9.4m $0.5m −$9.9m
FCF post-lease −$9.4m $0.5m −$9.9m
FCF / NPAT -58.7% 2.6% complementary conversion metric
Capex % revenue 10.8% 4.7%
Capex $9.4m $4.0m +$5.4m
Inventory days 300.6 189.1 +111.5 days
Net debt −$18.4m −$3.6m −$14.8m
Net debt / EBITDA -0.66x -0.14x Strengthening
Gross borrowings $7.3m $16.3m −$9.0m
ROE (annualised) 11.5% 15.7% Weakening
HY22 share of FY22 revenue 49.7% Other half was 50.3%
HY22 share of FY22 NPAT 57.2% Other half was 42.8%
Profit from continuing operations $16.0m $18.9m −$2.9m

Reference: annolyse.ai/briefings/rak-hy23


This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Metric context

Trajectory before this result

A compact view of the company's recent revenue and margin path, derived from the same metrics history that powers the company page.

RAK revenue trajectory

Revenue context before the current result.

RAK EBITDA margin

Earnings margin across covered periods.

Appendix

Reference material

Company materials considered in this briefing.

Current period

Rakon 1H23 Interim Report

HY23 / financial report

Rakon 1H23 Results Announcement

HY23 / results announcement

Rakon 1H23 Results Announcement

HY23 / results release

Prior comparable period

Rakon 1H22 Interim Report

HY22 / financial report

Rakon 1H22 Results Announcement

HY22 / results announcement

Rakon 1H22 Results Announcement

HY22 / results release

Full-year context

Rakon Annual Report 2022

FY22 / financial report

Rakon FY22 Results Announcement

FY22 / results announcement

Rakon FY22 Results Announcement

FY22 / results release

Email updates

Want briefings like this for the next reporting season?

Get the next Annolyse briefing by email when it is published.